Comparison of Two Multifocal Contact Lenses
Primary Purpose
Presbyopia
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Lotrafilcon B contact lens
Comfilcon A contact lens
Sponsored by
About this trial
This is an interventional treatment trial for Presbyopia
Eligibility Criteria
Inclusion Criteria:
- At least 35 years of age.
- Sign written Informed Consent
- Spectacle add of +0.50 to +2.50D.
- Best corrected visual acuity of at least 20.30 in both eyes.
- Currently wearing soft contact lenses at least 5 days per week.
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Eye injury or surgery within twelve weeks of enrollment.
- Currently enrolled in any clinical trial.
- Astigmatism > 1.00D.
- Strabismus/amblyopia.
- Other protocol-defined exclusion criteria may apply.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Other
Arm Label
Lotrafilcon B / Comfilcon A
Comfilcon A /Lotrafilcon B
Arm Description
Lotrafilcon B multifocal contact lenses worn first, with comfilcon A multifocal contact lenses worn second. Each product worn bilaterally on a daily wear basis for one week.
Comfilcon A multifocal contact lenses worn first, with lotrafilcon B multifocal contact lenses worn second. Each product worn bilaterally on a daily wear basis for one week.
Outcomes
Primary Outcome Measures
Overall Vision
Overall vision, as interpreted by the participant and recorded by the investigator as a single, retrospective evaluation of one week's wear time. Overall vision was measured on a 10-point scale, with 1 being worst and 10 being best.
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01250054
Brief Title
Comparison of Two Multifocal Contact Lenses
Study Type
Interventional
2. Study Status
Record Verification Date
July 2011
Overall Recruitment Status
Completed
Study Start Date
October 2010 (undefined)
Primary Completion Date
October 2010 (Actual)
Study Completion Date
October 2010 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
CIBA VISION
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to compare two multifocal contact lenses in presbyopic wearers.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Presbyopia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Participant
Allocation
Randomized
Enrollment
17 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Lotrafilcon B / Comfilcon A
Arm Type
Other
Arm Description
Lotrafilcon B multifocal contact lenses worn first, with comfilcon A multifocal contact lenses worn second. Each product worn bilaterally on a daily wear basis for one week.
Arm Title
Comfilcon A /Lotrafilcon B
Arm Type
Other
Arm Description
Comfilcon A multifocal contact lenses worn first, with lotrafilcon B multifocal contact lenses worn second. Each product worn bilaterally on a daily wear basis for one week.
Intervention Type
Device
Intervention Name(s)
Lotrafilcon B contact lens
Other Intervention Name(s)
AIR OPTIX AQUA MULTIFOCAL
Intervention Description
Commercially marketed, silicone hydrogel, multifocal contact lens for daily wear use
Intervention Type
Device
Intervention Name(s)
Comfilcon A contact lens
Other Intervention Name(s)
BIOFINITY MULTIFOCAL
Intervention Description
Commercially marketed (Europe), silicone hydrogel, multifocal contact lens for daily wear use
Primary Outcome Measure Information:
Title
Overall Vision
Description
Overall vision, as interpreted by the participant and recorded by the investigator as a single, retrospective evaluation of one week's wear time. Overall vision was measured on a 10-point scale, with 1 being worst and 10 being best.
Time Frame
One week of wear
10. Eligibility
Sex
All
Minimum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
At least 35 years of age.
Sign written Informed Consent
Spectacle add of +0.50 to +2.50D.
Best corrected visual acuity of at least 20.30 in both eyes.
Currently wearing soft contact lenses at least 5 days per week.
Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
Eye injury or surgery within twelve weeks of enrollment.
Currently enrolled in any clinical trial.
Astigmatism > 1.00D.
Strabismus/amblyopia.
Other protocol-defined exclusion criteria may apply.
12. IPD Sharing Statement
Learn more about this trial
Comparison of Two Multifocal Contact Lenses
We'll reach out to this number within 24 hrs